Alerts will be sent to your verified email
Verify EmailSURAKSHA
Suraksha Diagnostic
|
Dr. Lal Pathlabs
|
Metropolis Health.
|
|
---|---|---|---|
Operational Metrics
|
|||
Diagnostics
|
|||
Realization/Patient - Diagnostic Centres
|
2084.0 Rs/Patient | 754.0 Rs/Patient | 1053.0 Rs/Patient |
Number of Daily Patients - Diagnostic Centres
|
5.0 Ths | 76.67 Ths | 34.0 Ths |
Operating Margin/Test - Diagnostic Centres
|
133.64 Rs/Test | n/a | n/a |
No of Tests - Quarterly
|
1.62 Mn | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
10.2 % | 20.39 % | 20.1 % |
5yr average Equity Multiplier
|
1.52 | 1.37 | 1.71 |
5yr Average Asset Turnover Ratio
|
0.85 | 0.93 | 0.78 |
5yr Avg Net Profit Margin
|
7.83 % | 15.97 % | 14.74 % |
Price to Book
|
8.21 | 11.56 | 7.59 |
P/E
|
68.62 | 55.49 | 59.0 |
5yr Avg Cash Conversion Cycle
|
-168.38 Days | -120.56 Days | -95.51 Days |
Inventory Days
|
11.0 Days | 9.03 Days | 12.81 Days |
Days Receivable
|
11.31 Days | 12.15 Days | 37.5 Days |
Days Payable
|
166.84 Days | 121.86 Days | 137.0 Days |
5yr Average Interest Coverage Ratio
|
7.69 | 18.41 | 12.67 |
5yr Avg ROCE
|
13.1 % | 26.98 % | 22.23 % |
5yr Avg Operating Profit Margin
|
23.02 % | 26.39 % | 26.81 % |
5 yr average Debt to Equity
|
0.1 | 0.08 | 0.07 |
5yr CAGR Net Profit
|
9.21 % | 9.63 % | 0.08 % |
5yr Average Return on Assets
|
6.92 % | 14.9 % | 11.78 % |
Shareholdings
|
|||
Promoter Holding
|
48.78 % | 53.91 % | 48.9 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 1.18 % |
Change in Promoter Holding (3 Yrs)
|
-14.18 % | -1.32 % | -0.89 % |
Change in Mutual Fund Holding (3 Yrs)
|
19.26 % | 9.52 % | 12.28 % |
Suraksha Diagnostic
|
Dr. Lal Pathlabs
|
Metropolis Health.
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Customer Segment
|
Customer Segment
|
-
|
Customer Segment
|